SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-344559
Filing Date
2012-08-09
Accepted
2012-08-08 18:23:06
Documents
10
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d393485d10q.htm 10-Q 1198036
2 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 d393485dex311.htm EX-31.1 9972
3 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 d393485dex312.htm EX-31.2 9865
4 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER AND THE CHIEF FINANCIAL OFFICER d393485dex321.htm EX-32.1 5495
  Complete submission text file 0001193125-12-344559.txt   10076292

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mrx-20120630.xml EX-101.INS 1861298
6 XBRL TAXONOMY EXTENSION SCHEMA mrx-20120630.xsd EX-101.SCH 57170
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mrx-20120630_cal.xml EX-101.CAL 103980
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mrx-20120630_def.xml EX-101.DEF 262085
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mrx-20120630_lab.xml EX-101.LAB 531598
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mrx-20120630_pre.xml EX-101.PRE 480897
Mailing Address 7720 DOBSON ROAD SCOTTSDALE AZ 85256
Business Address 7720 DOBSON ROAD SCOTTSDALE AZ 85256 2125992000
MEDICIS PHARMACEUTICAL CORP (Filer) CIK: 0000859368 (see all company filings)

IRS No.: 521574808 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14471 | Film No.: 121018016
SIC: 2834 Pharmaceutical Preparations